Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancerAntroula Papakonstantinou, Elham Hedayati, Mats Hellström, et al.
Ebiomedicine|April 25, 2026
Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironmentAnastasia Magoulopoulou, Maria Chatzinikolaou, Andreas Metousis, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 5, 2020
Vitamin K intake and breast cancer incidence and death: results from a prospective cohort studyKang Wang, Qianxue Wu, Zhuyue Li, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysisPanagiotis Filis, Georgios Markozannes, Dimitrios Salgkamis, et al.
Thyroid : Official Journal of the American Thyroid Association|July 16, 2010
Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinomaAnastasios Sofiadis, Andrii Dinets, Lukas M Orre, et al.
Journal of the National Cancer Institute|January 22, 2025
Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementationIoannis Zerdes, Panagiotis Filis, Georgios Fountoukidis, et al.
The Lancet Regional Health. Europe|December 20, 2024
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialAlexios Matikas, Andri Papakonstantinou, Sibylle Loibl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
European Journal of Endocrinology|January 26, 2012
Proteomic profiling of follicular and papillary thyroid tumorsAnastasios Sofiadis, Susanne Becker, Ulf Hellman, et al.
Endocrine-Related Cancer|March 31, 2007
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paragangliomaJanos Geli, Nimrod Kiss, Fredrik Lanner, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancerAntroula Papakonstantinou, Elham Hedayati, Mats Hellström, et al.
Ebiomedicine|April 25, 2026
Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironmentAnastasia Magoulopoulou, Maria Chatzinikolaou, Andreas Metousis, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 5, 2020
Vitamin K intake and breast cancer incidence and death: results from a prospective cohort studyKang Wang, Qianxue Wu, Zhuyue Li, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysisPanagiotis Filis, Georgios Markozannes, Dimitrios Salgkamis, et al.
Thyroid : Official Journal of the American Thyroid Association|July 16, 2010
Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinomaAnastasios Sofiadis, Andrii Dinets, Lukas M Orre, et al.
Journal of the National Cancer Institute|January 22, 2025
Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementationIoannis Zerdes, Panagiotis Filis, Georgios Fountoukidis, et al.
The Lancet Regional Health. Europe|December 20, 2024
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialAlexios Matikas, Andri Papakonstantinou, Sibylle Loibl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
European Journal of Endocrinology|January 26, 2012
Proteomic profiling of follicular and papillary thyroid tumorsAnastasios Sofiadis, Susanne Becker, Ulf Hellman, et al.
Endocrine-Related Cancer|March 31, 2007
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paragangliomaJanos Geli, Nimrod Kiss, Fredrik Lanner, et al.
Pageof 13